Pythia Labs Launches with AI-Designed Antibodies for Hard-to-Drug Targets
LOS ANGELES & SAN DIEGO–(BUSINESS WIRE)– #AI–Pythia Labs, a biotechnology company building frontier AI models for therapeutic discovery, today announced its launch alongside a preprint in bioRxiv introducing Pythia-1, the all-atom generative model at the […]
